Sanofi and Google will together establish a new virtual Innovation Lab which use emerging data technologies to “radically transform” how future medicines and services are delivered.
The collaboration aims to change how Sanofi develops new treatments and will focus on three key objectives: to better understand patients and diseases; to increase Sanofi’s operational efficiency, and to improve the experience of Sanofi’s patients and customers.
“We stand on the forefront of a new age for biology and human health, with the opportunity to transform healthcare through partnerships with pioneering technology and analytics companies,” says Ameet Nathwani, Chief Digital Officer, Chief Medical Officer & Executive Vice President, Medical at Sanofi. “
Combining Sanofi’s biologic innovations and scientific data with Google’s industry-leading capabilities, from cloud computing to state-of-the-art artificial intelligence, we aspire to give people more control over their health and accelerate the discovery of new therapies.”
The companies will leverage deep analytics across data sets to better understand key diseases and extract related patient insights.
This will enable Sanofi to research and develop more personalised approaches to treatment and identify accompanying technologies to improve health outcomes.
The companies will apply technology and analytics on Sanofi’s large real-world database to better understand what treatments work for patients. This aims to result in an improved ability to offer personalized treatment advice, thus optimising patient care and reducing healthcare costs.
Sanofi and Google also plan to apply AI across diverse datasets to better forecast sales and inform marketing and supply chain efforts.
Using AI will take into account real-time information as well as geographic, logistic and manufacturing constraints to help the accuracy of these complex activities.